XML 38 R31.htm IDEA: XBRL DOCUMENT v3.25.3

Segment Information (Tables)

9 Months Ended

Sep. 30, 2025

Segment Reporting [Abstract]

Schedule of Reconciliation of Significant Segment Expenses

A reconciliation of the Company’s significant segment expenses to net loss is as follows:

		Three Months Ended September 30,								Nine Months Ended September 30,
(in thousands)		2025				2024				2025				2024
External R&D program expenses:
ARTISTRY-6		$	(4,802	)		$	3,075			$	3,898			$	6,907
ARTISTRY-7			(71	)			4,801				4,778				15,591
Early discovery programs			11				700				5,341				2,142
Other external R&D program expenses(1)			77				8,737				16,217				25,198
Total external R&D program expenses			(4,785	)			17,313				30,234				49,838
Internal R&D expenses:
Employee-related			493				7,635				12,386				24,143
Other internal R&D expenses(2)			4				2,637				3,794				8,016
Total internal R&D expenses			497				10,272				16,180				32,159
Total R&D expenses			(4,288	)			27,585				46,414				81,997
G&A expenses:
Employee-related			980				3,443				6,823				11,170
Other G&A expenses(3)			7,274				3,070				16,469				9,241
Total G&A expenses			8,254				6,513				23,292				20,411
Restructuring expenses:
Employee-related			—				—				9,457				—
Other restructuring expenses(4)			—				—				8,029				—
Total restructuring expenses:			—				—				17,486				—
Other segment (income) expense(5)			(260	)			(2,339	)			(2,367	)			(8,168	)
Segment net loss		$	3,706			$	31,759			$	84,825			$	94,240

(1) Other external R&D program expenses included in segment net loss include expenses related to other clinical trials and general external program expenses.

(2) Other internal R&D expenses included in segment net loss include expenses related to occupancy and depreciation.

(3) Other G&A expenses included in segment net loss include expenses related to professional fees, information technology, depreciation, and other general G&A expenses.

(4) Other restructuring expenses include contract termination costs, impairment and asset write-offs incurred in connection with our reduction-in-force and the termination of certain development programs.

(5) Other non-operating (income) expense included in segment net loss includes interest income, tax expense, and other non-operating income and expense.

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration